Oniria Therapeutics raises $2 million for oncology drug

by ONIRIA Therapeutics

Founded in 2022 as a spin-off from Vall d'Hebron Institut d'Oncologia, the University of Barcelona and Icrea, Oniria Therapeutics specialises in the development of targeted therapies to eliminate pers...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

A study shows the benefits of physical e...

by Institut de Recerca Biomèdica Catalunya Sud - IRB CatSud

The positive outcomes have led to the launch of a new project, which w...

Photos Stream